PHVS·N69605108·US·equity·Healthcare - Biotechnology-13D/G
PHVS (PHARVARIS N V) is held by 56 institutional investors as of Q1 2026. Largest holders: FMR LLC ($177.5M), VIKING GLOBAL INVESTORS LP ($103.2M), WELLINGTON MANAGEMENT GROUP LLP ($59.9M). Net institutional sentiment: Mixed.
See how PHVS's score breaks down across 4 SEC sources
Showing 1-20 of 60
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer